About us
IPHARMA is a well-established CRO that manages clinical trials in Russia and EAEU. Clinical branch of ChemRar group, and partner of Skolkovo Innovative center.
IPHARMA qualified staff (N=90)
Education
Experience
Role at IPHARMA
Natalia RABINOVICH,
General Director
Master in Finance from Stockholm University in 2005
Over 15 years of management in chemical and pharmaceutical industry
General management of IPHARMA since 2013
Oversees all financial operations and strategic partnerships
Education
Experience
Role at IPHARMA
Vyacheslav ROGOV,
Chief Operating Officer
Law school of Moscow Economic and Legal University in 2010
Over 10 years in clinical research (jurisprudence, audit, compliance)
Member of the Ethics Committee
Head of the Expert Group 2.2-2.4, Laboratory of program managemen and projects development in the field of Living Systems
Chief Operating Officer since 2021
Oversees all the regulatory and legal compliance during the processes related to planning, conducting of clinical trials and information data processing
Clinical Department
IPHARMA clinical team consists of qualified staff with the medical, pharmaceutical and biological education. Medical and GCP knowledge let them provide high quality of data, qualified study documents and patients safety.
Careful management of a clinical study is of paramount importance; and IPHARMA’s well-trained Project Managers oversee all study aspects with careful attention to detail.
Project Manager coordinates all study activities and reports to the Sponsor (or its designee), oversees the study’s clinical team, and works closely with other departments.
Medical Department
Local fluency is critical when evaluating medical information and communicating with Principal Investigators in Russia. Most helpful is when it is combined with fluency in English, facilitating interactions with Sponsors.
IPHARMA can provide medical expertise and safety oversight for clinical trials. Our Medical Advisors are fluent in Russian and English; and hold MDs and PhDs with substantial clinical experience in the following major therapeutic areas.
Education
Experience
Role at IPHARMA
Julia TRAKHTENBERG,
Medical Director
MD from Moscow Medical Academy n.a. I.M. Sechenov in 1997
Residency and postgraduate studies in Endocrinology and Diabetology in 1997-2006
PhD from Russian Medical Academy of Postgraduate Education in 2006
Over 17 years in clinical research (investigator research work, medical monitoring)
Head of the Medical department since 2012
Oversees all medical writing and safety monitoring activities
Data Management Department
Education
Experience
Role at IPHARMA
Pavel KHOLKIN,
DM Director
Graduated from the State University of Management in 1996 and the Project Management Institute in 2016
EDC development and management in Phase I-IV, BE and post-marketing trials
Head of IPHARMA DM Department since 2017
Regulatory Affairs Department
Regulatory Department is responsible for registering new drugs in Russia and the CIS, applying for chemical substance registration, as well as the registration of dietary supplements and medical devices.
Education
Experience
Role at IPHARMA
Diana SAPOZHNIKOVA,
Director of Regulatory Affairs
Graduated from the Moscow Medical Academy in 2003; PhD in 2006
Over 15 years in clinical research (medical associate, medical director, regulatory affairs)
Registration of original, generic, and biosimilar drugs of Russian and foreign MAHs
Head of the Regulatory Affairs Department of IPHARMA since 2018
Quality Assurance Department
The foundation of IPHARMA’s Quality management system is strict compliance to ICH GCP requirements and local regulations.
Education
Experience
Role at IPHARMA
Oksana KARAVAEVA,
Director of Clinical Operations
MD from Smolensk Medical Academy in 1998
Residency in Endocrinologyin 1998-2001
Over 19 years in clinical research (clinical operations, data management)
Head of the Clinical department since 2012
Oversees all project management and monitoring activities
Business Development Department
Analysis of possibilities to promote the company and representation of IPHARMA in the Russian and foreign markets, new business development, the development and improvement of relationships with customers.
Education
Experience
Role at IPHARMA
Roman BEZDUDNY,
BD Director
National Research University Higher School of Economics in 2003
Over 19 years in marketing and business development
Head of the BD department since 2021
Oversees all operations for IPHARMA business activities and managment key relationships clients
Administrative Department
The employees of the department control the document turnaround during clinical trials and control compliance with the local legislation. They control the regulatory and legal compliance during the process related to planning, conducting of clinical trials and information data processing.